Open access · CC-BY
via OpenAlex
Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?
Meng Kou, Li Huang, Jinjuan Yang, Zhixin Chiang, Shaoxiang Chen, Jie Liu, Liyan Guo, Xiaoxian Zhang, Xiaoya Zhou, Xiang Xu, Xiaomei Yan, Yan Wang, Jinqiu Zhang, Aimin Xu, Hung‐Fat Tse
Cell Death and Disease · 2022 · ▲ 605 citations
Abstract
Mesenchymal stem cells (MSCs) can be widely isolated from various tissues including bone marrow, umbilical cord, and adipose tissue, with the potential for self-renewal and multipotent differentiation. There is compelling evidence that the therapeutic effect of MSCs mainly depends on their paracrine action. Extracellular vesicles (EVs) are fundamental paracrine effectors of MSCs and play a crucial role in intercellular communication, existing in various body fluids and cell supernatants. Since MSC-derived EVs retain the function of protocells and have lower immunogenicity, they have a wide range of prospective therapeutic applications with advantages over cell therapy. We describe some characteristics of MSC-EVs, and discuss their role in immune regulation and regeneration, with emphasis on the molecular mechanism and application of MSC-EVs in the treatment of fibrosis and support tissue repair. We also highlight current challenges in the clinical application of MSC-EVs and potential ways to overcome the problem of quality heterogeneity.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41419-022-05034-x
- Canonical
- link ↗
- Fetched
- 2026-07-26 MST
Cite this
APA
Kou, M., Huang, L., Yang, J., Chiang, Z., Chen, S., Liu, J., Guo, L., Zhang, X., Zhou, X., Xu, X., Yan, X., Wang, Y., Zhang, J., Xu, A., Tse, H., & Lian, Q. (2022). Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?. <em>Cell Death and Disease</em>. https://doi.org/10.1038/s41419-022-05034-x
Vancouver
Kou M, Huang L, Yang J, Chiang Z, Chen S, Liu J, et al. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?. Cell Death and Disease. 2022. doi:10.1038/s41419-022-05034-x.
BibTeX
@article{meng2022Mesenc,
title = {Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?},
author = {Meng Kou and Li Huang and Jinjuan Yang and Zhixin Chiang and Shaoxiang Chen and Jie Liu and Liyan Guo and Xiaoxian Zhang and Xiaoya Zhou and Xiang Xu and Xiaomei Yan and Yan Wang and Jinqiu Zhang and Aimin Xu and Hung‐Fat Tse and Qizhou Lian},
journal = {Cell Death and Disease},
year = {2022},
doi = {10.1038/s41419-022-05034-x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cellular and Molecular Life Sciences 2020
Open access · CC-BY
Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy
Cells 2020
Open access · CC-BY
Role of Human Mesenchymal Stem Cells in Regenerative Therapy
Stem Cell Research & Therapy 2023
Open access · CC-BY
The heterogeneity of mesenchymal stem cells: an important issue to be addressed in cell therapy
Molecular Cancer 2022
Open access · CC-BY
Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential
Cell Transplantation 2013
Open access · OA
Paracrine Mechanisms of Mesenchymal Stem Cell-Based Therapy: Current Status and Perspectives
Frontiers in Neuroscience 2024
Open access · CC-BY